Network Version
Product Name: | SNS-032 | |
---|---|---|
CAS No.: | 345627-80-7 | |
Cat. No.: | HY-10008 | |
MWt: | 380.53 | |
Formula: | C17H24N4O2S2 | |
Purity : | >98% | |
Solubility: | DMSO : 33.33 mg/mL (87.59 mM; Need ultrasonic) | |
Mechanisms: | Target: Cancer | |
Biological Activity: | ||
SNS-032 (BMS-387032) is a potent and selective inhibitor of CDK2, CDK7, and CDK9 with IC50s of 38 nM, 62 nM and 4 nM, respectively. SNS-032 has antitumor effect[1]. IC50 & Target: IC50: 38 nM (CDK2), 62 nM (CDK7), 4 nM (CDK9)[1] In Vitro: SNS-032 has low sensitivity to CDK1 and CDK4 with IC50 of 480 nM and 925 nM, respectively. SNS-032 effectively kills chronic lymphocytic leukemia cells in vitro regardless of prognostic indicators and treatment history. Compared with flavopiridol and roscovitine, SNS-032 is more potent, both in inhibition of RNA synthesis and at induction of apoptosis. SNS-032 activity is readily reversible; removal of SNS-032 reactivates RNA polymerase II, which led to resynthesis of Mcl-1 and cell survival[1]. SNS-032 inhibits three dimensional capillary network formations of endothelial cells. SNS-032 completely prevents U87MG cell–mediated capillary formation of HUVECs. In addition, SNS-032 significantly prevents the production of VEGF in both cell lines, SNS-032 prevents in vitro angiogenesis, and this action is attributable to blocking of VEGF. Preclinical studies have shown that SNS-032 induces cell cycle arrest and apoptosis across multiple cell lines[2]. SNS-032 blocks the cell cycle via inhibition of CDKs 2 and 7, and transcription via inhibition of CDKs 7 and 9. SNS-032 activity is unaffected by human serum[3]. SNS-032 induces a dose-dependent increase in annexin V staining and caspase-3 activation. At the molecular level, SNS-032 induces a marked dephosphorylation of serine 2 and 5 of RNA polymerase (RNA Pol) II and inhibits the expression of CDK2 and CDK9 and dephosphorylated CDK7[5]. In Vivo: SNS-032 (15 mg/kg, i.p.) inhibits both xenografted BaF3-T674I cells and KBM5-T315I cells in vivo. SNS-032 abrogates the growth of tumors transplanted in nude mice with downregulation of T674I PDGFRα and T315I-Bcr-Abl[4]. |
1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA
Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected] Web:www.medchemexpress.com
Keywords: buy SNS-032 | SNS-032 Supplier | purchase SNS-032 | SNS-032 cost | SNS-032 manufacturer | order SNS-032 | SNS-032 distributor | SNS-032 structure buy 345627-80-7 | 345627-80-7 Supplier | purchase 345627-80-7 | 345627-80-7 cost | 345627-80-7 manufacturer | order 345627-80-7 | 345627-80-7 distributor | 345627-80-7 structure